161 related articles for article (PubMed ID: 8816750)
1. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system.
Chen ST; Iida A; Guo L; Friedmann T; Yee JK
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10057-62. PubMed ID: 8816750
[TBL] [Abstract][Full Text] [Related]
2. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system.
Iida A; Chen ST; Friedmann T; Yee JK
J Virol; 1996 Sep; 70(9):6054-9. PubMed ID: 8709228
[TBL] [Abstract][Full Text] [Related]
3. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory DS; Neugeboren BA; Mulligan RC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
[TBL] [Abstract][Full Text] [Related]
4. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
[TBL] [Abstract][Full Text] [Related]
5. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression.
Yoshida Y; Emi N; Hamada H
Biochem Biophys Res Commun; 1997 Mar; 232(2):379-82. PubMed ID: 9125185
[TBL] [Abstract][Full Text] [Related]
6. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.
Arai T; Matsumoto K; Saitoh K; Ui M; Ito T; Murakami M; Kanegae Y; Saito I; Cosset FL; Takeuchi Y; Iba H
J Virol; 1998 Feb; 72(2):1115-21. PubMed ID: 9445007
[TBL] [Abstract][Full Text] [Related]
7. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
8. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
[TBL] [Abstract][Full Text] [Related]
9. Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors.
Manning WC; Murphy JE; Jolly DJ; Mento SJ; Ralston RO
J Virol Methods; 1998 Jul; 73(1):31-9. PubMed ID: 9705172
[TBL] [Abstract][Full Text] [Related]
10. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
11. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
12. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors.
Lo HL; Yee JK
Curr Protoc Hum Genet; 2007 Jan; Chapter 12():Unit 12.7. PubMed ID: 18428407
[TBL] [Abstract][Full Text] [Related]
13. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Yee JK; Friedmann T; Burns JC
Methods Cell Biol; 1994; 43 Pt A():99-112. PubMed ID: 7823872
[TBL] [Abstract][Full Text] [Related]
14. Lack of superinfection interference in retroviral vector producer cells.
Vogt B; Roscher S; Abel B; Hildinger M; Lamarre A; Baum C; von Laer D
Hum Gene Ther; 2001 Mar; 12(4):359-65. PubMed ID: 11242528
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
Arai T; Takada M; Ui M; Iba H
Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
[TBL] [Abstract][Full Text] [Related]
16. Inducible vesicular stomatitis virus (VSV) L cell line for packaging of recombinant VSV.
Hong SK; Jung YT; Park SW; Paik SY
Virus Genes; 2005 Oct; 31(2):195-201. PubMed ID: 16025245
[TBL] [Abstract][Full Text] [Related]
17. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
Burns JC; Friedmann T; Driever W; Burrascano M; Yee JK
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8033-7. PubMed ID: 8396259
[TBL] [Abstract][Full Text] [Related]
18. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes.
Gallardo HF; Tan C; Ory D; Sadelain M
Blood; 1997 Aug; 90(3):952-7. PubMed ID: 9242523
[TBL] [Abstract][Full Text] [Related]
19. Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors.
Yu JH; Schaffer DV
J Virol; 2006 Apr; 80(7):3285-92. PubMed ID: 16537595
[TBL] [Abstract][Full Text] [Related]
20. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
